Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immuno... by Andrea Lombardi, Giulia Viero, Simone Villa, Simona Biscarini, Emanuele Palomba, Cecilia Azzarà, Nathalie Iannotti, Bianca Mariani, Camilla Genovese, Mara Tomasello, Anna Tonizzo, Marco Fava, Antonia Grazia Valzano, Letizia Corinna Morlacchi, Maria Francesca Donato, Giuseppe Castellano, Ramona Cassin, Maria Carrabba, Antonio Muscatello, Andrea Gori, Alessandra Bandera

Subjects: Get full text

Retrospective Analysis of a Real-Life Use of Tixagevimab–Cilgavimab plus SARS-CoV-2 Antivirals for Treatment of COVID-19 by Nicolina Capoluongo, Annamaria Mascolo, Francesca Futura Bernardi, Marina Sarno, Valentina Mattera, Giusy di Flumeri, Bruno Pustorino, Micaela Spaterella, Ugo Trama, Annalisa Capuano, Alessandro Perrella

Subjects: Get full text

Real-world clinical outcomes of tixagevimab/cilgavimab in the Omicron outbreak in China: baseline characteristics and interim analysis of the CLEAR study by Jianhua You, Haidi Wu, Jiaxin Tian, Jianru Wen, Wenbo Shi, Zhi Wang, Yanjun Du, Hongwei Xu, Hanyu Wei, Xiang Li, Wenyan Kang, Min Zhou, Zhidong Gu, Jieming Qu

Subjects: Get full text

Editorial: Covid-19 therapies in patients with hematologic malignancies by Andrea Visentin, Massimo Gentile, Massimo Gentile

Subjects: Get full text

Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period by Daria S. Fomina, Daria S. Fomina, Marina S. Lebedkina, Anna A. Iliukhina, Anna V. Kovyrshina, Artem Y. Shelkov, Sergey S. Andreev, Anton A. Chernov, Inna V. Dolzhikova, Tatyana S. Kruglova, Gerelma V. Andrenova, Amir I. Tukhvatulin, Dmitry V. Shcheblyakov, Alexander V. Karaulov, Maryana A. Lysenko, Maryana A. Lysenko, Denis Y. Logunov, Alexander L. Gintsburg, Alexander L. Gintsburg

Subjects: Get full text

Efficacy of Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against Infection from SARS-CoV-2 and Severe COVID-19 among Heavily Immunocompromised Patients: A Single-Center, Pros... by Dimitrios Basoulis, Elpida Mastrogianni, Georgios Karamanakos, Aikaterini Gkoufa, Vasiliki E. Georgakopoulou, Sotiria Makrodimitri, Maria N. Gamaletsou, Antonios Markogiannakis, Nikolaos V. Sipsas

Subjects: Get full text

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry by Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, Federico Itri, Caroline Besson, Julio Dávila-Valls, Sonia Martín-Pérez, Luana Fianchi, Laman Rahimli, Giuseppe Tarantini, Federica Irene Grifoni, Mariarita Sciume, Jorge Labrador, Raul Cordoba, Alberto López-García, Nicola S. Fracchiolla, Francesca Farina, Emanuele Ammatuna, Antonella Cingolani, Daniel García-Bordallo, Stefanie K. Gräfe, Yavuz M. Bilgin, Michelina Dargenio, Tomás José González-López, Anna Guidetti, Tobias Lahmer, Esperanza Lavilla-Rubira, Gustavo-Adolfo Méndez, Lucia Prezioso, Martin Schönlein, Jaap Van Doesum, Dominik Wolf, Ditte Stampe Hersby, Ferenc Magyari, Jens Van Praet, Verena Petzer, Carlo Tascini, Iker Falces-Romero, Andreas Glenthøj, Oliver A. Cornely, Livio Pagano

Subjects: Get full text

Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies by Anna A. Roppelt, Marina S. Lebedkina, Anton A. Chernov, Tatiana S. Kruglova, Olga A. Mukhina, Yulia D. Yukhnovskaya, Farida A. Samedova, Ulyana A. Mаrkina, Gerelma V. Andrenova, Alexander V. Karaulov, Mariana A. Lysenko, Daria S. Fomina

Subjects: Get full text

Immunogenicity and safety of tixagevimab-cilgavimab for COVID-19 pre-exposure prophylaxis in immunocompromised 20 to <40 kg children and adolescents: A pilot, prospective, open-lab... by Jassada Buaboonnam, Supattra Rungmaitree, Nuntawan Piyaphanee, Sirirat Charuvanij, Onsiri Pitisuttithum, Katherine Copeland, Chatkamol Pheerapanyawaranun, Laddawan Jansarikit, Suvimol Niyomnaitham, Kulkanya Chokephaibulkit

Subjects: “…Tixagevimab-cilgavimab…”
Get full text

Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study. by Giovanni Manfredi Assanto , Matteo Totaro, Poggiali Rebecca, Delli Paoli Adele, Annechini Giorgia, D’Elia Gianna Maria, Aji Francesco, Petrucci Luigi, Fazio Francesca, Del Giudice Ilaria, Martelli Maurizio, Micozzi Alessandra, Giuseppe Gentile

Subjects: Get full text

Efficacy and safety of patients immunization with chronic obstructive pulmonary disease with monoclonal antibodies by Vladimir N. Antonov, Galina L. Ignatova

Subjects: Get full text

Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients—A Tailored Approach Based on SARS-CoV-2 Vaccine Response by Krischan Braitsch, Samuel D. Jeske, Jacob Stroh, Maike Hefter, Louise Platen, Quirin Bachmann, Lutz Renders, Ulrike Protzer, Katharina S. Götze, Peter Herhaus, Mareike Verbeek, Christoph D. Spinner, Florian Bassermann, Marion Högner, Bernhard Haller, Jochen Schneider, Michael Heider

Subjects: Get full text

A case of prolonged COVID‐19 treated with tixagevimab/cilgavimab by Takahiro Shimizu, Hiroki Shirasaki, Kazuhiro Okafuji, Aiko Sawazaki, Tasuku Iwabuchi, Ryo Matubayashi

Subjects: Get full text

Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience by Karolina Akinosoglou, Emmanouil-Angelos Rigopoulos, Georgia Kaiafa, Stylianos Daios, Eleni Karlafti, Eleftheria Ztriva, Georgios Polychronopoulos, Charalambos Gogos, Christos Savopoulos

Subjects: Get full text

Prolonged COVID-19 Infection in a Patient with Complete Remission from Follicular Lymphoma with Hyperosmolar Hyperglycemic Syndrome by Takuya Omura, Akira Katsumi, Shuji Kawashima, Masahiro Naya, Haruhiko Tokuda

Subjects: Get full text

Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study by Hovav Azuly, Tali Shafat, Daniel Grupel, Tzvika Porges, Ran Abuhasira, Ana Belkin, Ofir Deri, Yonatan Oster, Shadi Zahran, Ehud Horwitz, Netanel A. Horowitz, Hazim Khatib, Marjorie Vieira Batista, Anita Cassoli Cortez, Tal Brosh-Nissimov, Yafit Segman, Linor Ishay, Regev Cohen, Alaa Atamna, Amy Spallone, Roy F. Chemaly, Juan Carlos Ramos, Michal Chowers, Evgeny Rogozin, Noga Carmi Oren, Şiran Keske, Orit Wolfovitz Barchad, Lior Nesher, on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV)

Subjects: Get full text

Efficacy and Safety of Tixagevimab/Cilgavimab to Prevent COVID-19 (Pre-Exposure Prophylaxis): A Systematic Review and Meta-Analysis by Saad Alhumaid, Abbas Al Mutair, Jalal Alali, Nourah Al Dossary, Sami Hussain Albattat, Sarah Mahmoud Al HajjiMohammed, Fatimah Saad Almuaiweed, Maryam Radhi AlZaid, Mohammed Jaber Alomran, Zainab Sabri Alqurini, Ahmed Abduljalil Alsultan, Thamer Saeed Alhajji, Sukainah Mohammad Alshaikhnasir, Ali Al motared, Koblan M. Al mutared, Khalid Hajissa, Ali A. Rabaan

Subjects: Get full text

COVID-19 Outcomes in Lung Transplant Recipients Following Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab During the Omicron BA.5 Surge: A Single Center Analysis by Saartje Demolder, Veronique Schaevers, Katrien Lagrou, Katrien Lagrou, Paul De Munter, Paul De Munter, Hanne Beeckmans, Geert M. Verleden, Geert M. Verleden, Laurent Godinas, Laurent Godinas, Lieven J. Dupont, Lieven J. Dupont, Pascal Van Bleyenbergh, Natalie Lorent, Natalie Lorent, Robin Vos, Robin Vos

Subjects: Get full text

COVID-19 Pharmacotherapy in Pregnancy: A Literature Review of Current Therapeutic Choices by Karolina Akinosoglou, Georgios Schinas, Emmanouil-Angelos Rigopoulos, Eleni Polyzou, Argyrios Tzouvelekis, George Adonakis, Charalambos Gogos

Subjects: Get full text

Tixagevimab/Cilgavimab as SARS-CoV-2 Pre-Exposure Prophylaxis in Lung Transplant Recipients during the Omicron Wave: A Real-World Monocentric Experience by Andrea Cona, Alessandro Tavelli, Stefano Agrenzano, Neha Hafeez, Giovanni Scianna, Angelo Maria, Francesco Marino, Elizabeth De La Cruz, Maria Di Giorgio, Eglys Osorio, Giuseppe Cucinella, Angelo Luca, Alessio Provenzani, Patrizio Vitulo, Alessandro Bertani, Paolo Antonio Grossi, Alessandra Mularoni

Subjects: Get full text